Cargando…

The synthetic integron: an in vivo genetic shuffling device

As the field of synthetic biology expands, strategies and tools for the rapid construction of new biochemical pathways will become increasingly valuable. Purely rational design of complex biological pathways is inherently limited by the current state of our knowledge. Selection of optimal arrangemen...

Descripción completa

Detalles Bibliográficos
Autores principales: Bikard, David, Julié-Galau, Stéphane, Cambray, Guillaume, Mazel, Didier
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2926619/
https://www.ncbi.nlm.nih.gov/pubmed/20534632
http://dx.doi.org/10.1093/nar/gkq511
_version_ 1782185713654038528
author Bikard, David
Julié-Galau, Stéphane
Cambray, Guillaume
Mazel, Didier
author_facet Bikard, David
Julié-Galau, Stéphane
Cambray, Guillaume
Mazel, Didier
author_sort Bikard, David
collection PubMed
description As the field of synthetic biology expands, strategies and tools for the rapid construction of new biochemical pathways will become increasingly valuable. Purely rational design of complex biological pathways is inherently limited by the current state of our knowledge. Selection of optimal arrangements of genetic elements from randomized libraries may well be a useful approach for successful engineering. Here, we propose the construction and optimization of metabolic pathways using the inherent gene shuffling activity of a natural bacterial site-specific recombination system, the integron. As a proof of principle, we constructed and optimized a functional tryptophan biosynthetic operon in Escherichia coli. The trpA-E genes along with ‘regulatory’ elements were delivered as individual recombination cassettes in a synthetic integron platform. Integrase-mediated recombination generated thousands of genetic combinations overnight. We were able to isolate a large number of arrangements displaying varying fitness and tryptophan production capacities. Several assemblages required as many as six recombination events and produced as much as 11-fold more tryptophan than the natural gene order in the same context.
format Text
id pubmed-2926619
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-29266192010-08-30 The synthetic integron: an in vivo genetic shuffling device Bikard, David Julié-Galau, Stéphane Cambray, Guillaume Mazel, Didier Nucleic Acids Res Methods Online As the field of synthetic biology expands, strategies and tools for the rapid construction of new biochemical pathways will become increasingly valuable. Purely rational design of complex biological pathways is inherently limited by the current state of our knowledge. Selection of optimal arrangements of genetic elements from randomized libraries may well be a useful approach for successful engineering. Here, we propose the construction and optimization of metabolic pathways using the inherent gene shuffling activity of a natural bacterial site-specific recombination system, the integron. As a proof of principle, we constructed and optimized a functional tryptophan biosynthetic operon in Escherichia coli. The trpA-E genes along with ‘regulatory’ elements were delivered as individual recombination cassettes in a synthetic integron platform. Integrase-mediated recombination generated thousands of genetic combinations overnight. We were able to isolate a large number of arrangements displaying varying fitness and tryptophan production capacities. Several assemblages required as many as six recombination events and produced as much as 11-fold more tryptophan than the natural gene order in the same context. Oxford University Press 2010-08 2010-06-09 /pmc/articles/PMC2926619/ /pubmed/20534632 http://dx.doi.org/10.1093/nar/gkq511 Text en © The Author(s) 2010. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/2.5 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methods Online
Bikard, David
Julié-Galau, Stéphane
Cambray, Guillaume
Mazel, Didier
The synthetic integron: an in vivo genetic shuffling device
title The synthetic integron: an in vivo genetic shuffling device
title_full The synthetic integron: an in vivo genetic shuffling device
title_fullStr The synthetic integron: an in vivo genetic shuffling device
title_full_unstemmed The synthetic integron: an in vivo genetic shuffling device
title_short The synthetic integron: an in vivo genetic shuffling device
title_sort synthetic integron: an in vivo genetic shuffling device
topic Methods Online
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2926619/
https://www.ncbi.nlm.nih.gov/pubmed/20534632
http://dx.doi.org/10.1093/nar/gkq511
work_keys_str_mv AT bikarddavid thesyntheticintegronaninvivogeneticshufflingdevice
AT juliegalaustephane thesyntheticintegronaninvivogeneticshufflingdevice
AT cambrayguillaume thesyntheticintegronaninvivogeneticshufflingdevice
AT mazeldidier thesyntheticintegronaninvivogeneticshufflingdevice
AT bikarddavid syntheticintegronaninvivogeneticshufflingdevice
AT juliegalaustephane syntheticintegronaninvivogeneticshufflingdevice
AT cambrayguillaume syntheticintegronaninvivogeneticshufflingdevice
AT mazeldidier syntheticintegronaninvivogeneticshufflingdevice